Serum N-Desmethylcitalopram Concentrations are Associated with the Clinical Response to Citalopram of Patients with Major Depression

Creative Commons License

ÖZBEY G., Yucel B., Bodur N. E. , Taycan S. E. , Arslan T., Cerit N., ...More

PSYCHIATRY INVESTIGATION, vol.15, no.3, pp.313-319, 2018 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 15 Issue: 3
  • Publication Date: 2018
  • Doi Number: 10.30773/pi.2017.05.22
  • Page Numbers: pp.313-319
  • Keywords: Serum concentration, Citalopram, N-desmethylcitalopram, Efficacy, Tolerability, Major depression, ANTIDEPRESSANT DRUGS, METABOLITES, POPULATION, PSYCHIATRY, INHIBITORS


Objective Citalopram (CITA) is a widely used and well-tolerated selective serotonin reuptake inhibitor. The aim of the study was to evaluate the possible influences of serum concentrations of CITA and its major metabolite n-desmethylcitalopram (NDCITA) on the efficacy and tolerability of CITA in patients with major depressive disorder.